Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

FASTENAL CO Director's Dealing 2023

Nov 13, 2023

29988_dirs_2023-11-13_ed816358-3349-4285-be70-0fe9c63741d0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FASTENAL CO (FAST)
CIK: 0000815556
Period of Report: 2023-11-10

Reporting Person: Lisowski Sheryl Ann (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2023-11-10 Common Stock M 3828 $23.50 Acquired 8924 Direct
2023-11-10 Common Stock S 3828 $60 Disposed 5096 Direct
2023-11-10 Common Stock M 6546 $27.50 Acquired 11642 Direct
2023-11-10 Common Stock S 6546 $60.0142 Disposed 5096 Direct
2023-11-10 Common Stock M 6922 $26 Acquired 12018 Direct
2023-11-10 Common Stock S 6922 $60.0124 Disposed 5096 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2023-11-10 Employee Stock Option (Right to Buy) $23.50 M 3828 Disposed 2026-12-31 Common Stock (3828) Direct
2023-11-10 Employee Stock Option (Right to Buy) $27.50 M 6546 Disposed 2027-12-31 Common Stock (6546) Direct
2023-11-10 Employee Stock Option (Right to Buy) $26 M 6922 Disposed 2028-12-31 Common Stock (6922) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 2006 Indirect

Footnotes

F1: Shares attributed to reporting person's account within issuer's 401(K) Plan and includes an additional 61 shares acquired since the reporting person's prior report filed on 7/18/2022.

F2: The option will fully vest and become exercisable over a period of five years, with 40% of the option vesting and becoming exercisable halfway

through the relevant vesting period and the remainder vesting and becoming exercisable proportionately (20%) each year thereafter.

F3: The option will vest and become exercisable over a period of five years, with 50% of the option vesting and becoming exercisable two years following the date of grant and the remainder vesting and becoming exercisable proportionately (20%) each year thereafter.